Circulating MiR-133a as a Biomarker Predicts Cardiac Hypertrophy in Chronic Hemodialysis Patients
Ping Wen(South China Normal University), Junwei Yang(Chongqing University), Dan Song(Kunming Medical University), Weichun He(Xinyang Normal University), Hongdi Cao(Second Affiliated Hospital of Nanjing Medical University), Chunsun Dai(Nanjing Medical University), Hong Ye(Second Affiliated Hospital of Nanjing Medical University), Yang Zhou(Wuhan University), Fang Li(Hebei General Hospital), Bing Tang(Second Affiliated Hospital of Nanjing Medical University), Lei Jiang(Wuhan City Chinese Medicine Hospital), Yafang Yang(Second Affiliated Hospital of Nanjing Medical University), Xiaochun Wu(National Center for Nanoscience and Technology)
Cited by 28
Related Papers
The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression
|American Journal of Physiology-Renal Physiology|2011|258
Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis
|American Journal of Physiology-Renal Physiology|2017|238
Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
|PLoS ONE|2013|230
WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression
|Experimental Cell Research|2016|222